12:00 AM
Jan 28, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Rexahn management update

Rexahn Pharmaceuticals Inc. (NYSE-M:RNN), Rockville, Md.
Business: Cancer, Neurology, Genitourinary

Read the full 34 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >